Elixinol Wellness in the News

    Elixinol Wellness to acquire Ananda Food  
    Study on the safety of Elixinol Hemp Extract is published in Journal of Toxicology  
    Stockhead's Health and Biotech Investor Guide  
    June quarter: biotech companies buck trend that says sector moves slowly  
    Business News Australia: Australia's top 20 cannabis companies  
    Hemp Foods Australia signs up top TV chef as ambassador  
    Masterchef’s Simon Toohey joins Hemp Foods Australia  
    Proactive Australia: Elixinol Wellness inks licence agreement with UK's leading cannabis producer  
    Inside FMCG: Woolworths listing shows hemp foods are moving mainstream  
    Yahoo Finance: California's Assembly Bill 45 Formally Permits CBD Sales  
    Proactive Investors: Elixinol Wellness feeling increasingly positive after 'significantly improved' first half earnings  
    Proactive Investors: Elixinol Wellness delivers best EBITDA and earnings since first half 2019  
    Ausbiz: Elixinol excited by half year results  
    Australian cannabis industry by The Market Herald  
    Proactive Investors: Elixinol Wellness returns to growth in June quarter  
    Fear and Greed Podcast: Inside the growing Australian hemp industry  
    Elixinol Global AGM approves rebrand to Elixinol Wellness; key appointments confirmed  
    Proactive Investor: Elixinol Wellness' core priorities to reignite US and UK businesses and integrate CannaCare  
    Elixinol's Oliver Horn Chats About the Hemp Movement  
    Cannabiz: Elixinol Global AGM approves rebrand to ElixinolWellness  
    The AFR: Hemp, cannabis markets on the cusp of ‘exciting’ expansion  
    Elixinol Share Price Up 12% after Acquiring CannaCare Health  
    Elixinol Global expands presence in European CBD market with CannaCare buyout  
    Cannabiz: Elixinol inks deal to buy German CBD company CannaCare  
    Proactive Investor: Elixinol Global accelerates growth strategy following global re-set of initiatives  
    Proactive Investors: Elixinol Global welcomes strong support for $8.2 million fundraise to accelerate growth strategyElixinol Global delighted as demand for its share purchase plan far exceeds target  
    StockDoc Podcast: Biden win has medicinal cannabis sector on high, EXL perfectly placed  
    Proactive Investors: Elixinol Global welcomes strong support for $8.2 million fundraise to accelerate growth strategy  
    The Market Herald: Elixinol Global (ASX:EXL) raises $8.2 million in extra working capital  
    The Motley Fool: Elixinol Global (ASX:EXL) shares blaze new highs  
    Ausbiz Interview: Oliver Horn discusses Q3 FY2020 results  
    Cannabiz: Elixinol Q3 Revenues up 18%  
    Stockhead: ScoPo’s powerplays: ‘The vibe feels good’  
    Ausbiz: Oliver's Army  
    The Green Fund: Elixinol Expects 10-15% Revenue Growth in Q3  
    Finance News Network: Elixinol Global (ASX:EXL) Trading Update  
    Cannabiz: Elixinol Global bullish after positive Q3 results  
    Stockhead: Elixinol Global looks to emerge from the ashes of cannabis collapse  
    Authority Magazine: Tom Siciliano of Elixinol  
    The Green Fund: EXL Improves Outlook in First Half 2020 Results  
    Finance News Network: Elixinol Global (ASX:EXL) key messages from 2020 AGM  
    Nutra Ingredients Asia: CBD supplements in Australia - Elixinol plots route to market via regulator’s special access scheme  
    Cannabiz: Low-dose CBD down scheduling is good news for consumers and the industry: Elixinol CEO  
    Ausbiz TV: Interview with Oliver Horn  
    The CBD Insider: Elixinol Goodnight CBD Capsules Review  
    Finance News Network: Elixinol Global enters into exclusive License Agreement in Japan  
    Business News Australia: Elixinol secures foothold in Australian market with PharmaCann agreement  
    Cannabiz: The Biz Interview with Oliver Horn, CEO, Elixinol Global  
    New Hope Network: New hemp CBD tests show it’s time to downsize and grow up  
    Elixinol Global (ASX:EXL) Presentation, FNN Online Investor Event, June 2020  
    Money Morning: Reports that cannabis and hemp are back in the US headlines and Elixinol is feeling a high... share price.  
    Money Morning: Reports Elixinol Global as top CBD stock due to its global reach and expanding operations  
    Business Report: Reports South Africa’s top health and beauty retailers, Clicks and Dis-Chem, are both rolling out the Elixinol range of CBD full-spectrum extract products in October.  
    Authority Magazine: An inspiring interview with Elixinol Global founder and CIO Paul Benhaim, sharing fantastic insights into his hemp journey.  
    Money Morning: Reports Elixinol share price is down from a top, but could be approaching support  
    Business News Australia: Reports on Elixinol Global remaining upbeat with its wholly owned US subsidiary continuing to gain distribution in nationally recognised retail outlets.  
    The Motley Fool: Reports Elixinol Global continues to strike deals with distribution partners, which has been critical to its early success  
    Motley Fool: Reports on Elixinol Global's supply agreement with Pet Releaf  
    SmallCaps: Reports Elixinol Global strikes exclusive multimillion-dollar deal with Pet Releaf  
    Yahoo Finance: Reports Elixinol acquires property rights over microencapsulated technology  
    Yahoo Finance: Reports that Elixinol Global shares' positive performance following the release of its second quarter update.  
    Elixinol Global Limited excited to announce partnership with PharmaCare establishing relationships in the UK.  
    The Motley Fool: Reports that Elixinol Global has been granted its manufacturing licence for medicinal cannabis.  
    Business News Australia: Reports that Elixinol Global has restructured its board ahead of an international push.  
    Business Insider Australia: Reports on Elixinol Global being the first cannabis company to launch a media campaign in London Underground.  
    B&T: Reports on Elixinol Global's industry-first media campaign using digital signage and video boards across London Underground.  
    AdNews: Reports on Elixinol being the first cannabis company to advertise on London Underground.  
    The Motley Fool: Reports on strategic partnership between Elixinol Global and RFI through a newly incorporated Colorado based entity Infusion Strategies.  
    Business News Australia: Reports on Elixinol Global and RFI entering JV creating new entity Infusion Strategies  
    The Daily Telegraph: Reports that Elixinol Global raises $50m for US expansion  
    The Motley Fool: Reports Elixinol Global raises $50 million to fund its global expansion  
    New Cannabis Ventures: Reports on Elixinol Global selling 12.8 million shares to fund CBD growth  
    Stockhead: Reports Elixinol Global raises another $50m, bringing total to $120m in 18 months  
    Stockhead: Reports that a third of US companies selling hemp CBD products are about to disappear, and that’s actually great news!  
    The Motley Fool: Reports that Elixinol Global’s share price has rocketed 90% higher so far this year and is a red hot option within the industrial hemp and medicinal cannabis industries.  
    Seeking Alpha: Reports that Elixinol's attractive valuation and large addressable market make it an investment worth considering  
    Food & Drinks Business: Reports on licensing delays due to an overworked and understaffed Office of Drug Control  
    “Elixinol pivots to pet pot treats, nabs 25pc stake in US hemp manufacturer” reports Stockhead  
    Finance News Network reports “Elixinol Global to buy into pet cannabis company”  
    Is Elixinol Global the Fastest Growing Hemp/CBD Producer? I Streetwise Reports  
    Elixinol Global Signalling Significant Bullish Breakout I Insider Financial  
    Women are naturally drawn to medical marijuana, says Elixinol Global MD I Stockhead  
    Will Pot Stocks Live Up to Their Promise? I The Bull  
    Elixinol Global: Seeing High Profits From Diverse Investments I The Green Fund  
    "The Pot Seat: Elixinol’s Paul Benhaim is spending to stay on top” reports Stockhead  
    Elixinol Global Makes Hemp Play in $215 Million Vegan Food Sector | The Green Fund  
    Elixinol Global FY2018 full year results investor conference call recording  
    Stockhead reports that Elixinol Global (ASX:EXL) more than doubled its revenue in 2018 and expects continued financial growth this year.  
    Your Money interviews EXL CEO Paul Benhaim about the company’s 2018 financial results and its plans for further growth.  
    New Cannabis Ventures reports on Elixinol Global’s FY2018 results.  
    Elixinol Global is listed in Small Caps' top 10 ASX IPOs in 2018.  
    Insider Financial reports on Elixinol Global's international strategy and continued strong growth  
    Finfeed reports on Elixinol Global's recent share price increase and the company's strong financial position in the global market  
    Stockhead reports on Elixinol Global’s growth opportunities in the US  
    ABC News reveals Elixinol Global was one of the best performing stocks to debut on the ASX in 2018  
    AFR reports on Elixinol Global’s success in 2018  
    Wall Street Reporter interviews Elixinol Global CEO Paul Benhaim about EXL's progress in the CBD and hemp consumer products and foods markets  
    Sydney Morning Herald looks at the rise of the CBD industry, as well as the recent passage of the US Farm Bill and the positive impact this is having on Elixinol Global  
    Stockhead interviews Elixinol Global CEO Paul Benhaim about Australia’s medicinal cannabis regulations  
    Small Caps says Elixinol Global marks first shipment to New Zealand  
    Stockhead reports on Elixinol Global crossing the Tasman into New Zealand  
    Finance News Network reports on Elixinol launching in New Zealand  
    The Green Fund lists Elixinol Global in its Top 3 Hemp Stocks for 2019  
    The Motley Fool reports that Elixinol Global is up 68% in 2018  
    The Fly talks to Elixinol Global’s CEO about the company, competition and hemp legalisation  
    Streetwise Reports reveals 15 reasons why Elixinol Global should be in your portfolio  
    CommSec TV: Executive Series interview with Elixinol Global’s CEO, Paul Benhaim discussing the pending US Farm Bill with Tom Piotrowski  
    Stockhead reports on pending US Farm Bill and talks to Elixinol Global’s Paul Benhaim  
    Elixinol Global set to benefit from nearing of US Farm Bill legislation  
    US Farm Bill set to legalise and commercialise industrial hemp  
    Hemp’s cognitive help: Elixinol’s supplements finding favour amongst Japanese consumers  
    News.com.au – Cannabis expert says we’re just scratching the surface in unlocking the plant’s potential  
    Business News Australia reports on Elixinol Global’s strong 3Q FY2018 results  
    New Cannabis Ventures reports on Elixinol Global’s 3Q FY2018 revenue growth  
    CFN Media Interviews Elixinol’s Director of Business Development, Ruben Gonzales  
    The Sydney Morning Herald reports on the ‘hemp boom’ in Australia and features an interview with EXL CEO Paul Benhaim  
    New Cannabis Ventures says Elixinol Global raises A$40 million to expand global CBD operations  
    CommSec TV: Executive Series interview with Elixinol Global’s CEO, Paul Benhaim  
    Elixinol Global is the sleeping giant of the Hemp Market reports The Green Fund  
    Elixinol Global featured in Biotech Daily’s weekly column ‘Dr Boreham’s Crucible’  
    “Hemp is hot” and Elixinol Global is positioned to take full advantage  
    Elixinol Global 'only company in the sector to list a profit'  
    Stockhead reports Elixinol Global is one of the world’s top cannabis companies  
    Elixinol Global listed as the only ASX cannabis stock making a profit following its 1H FY2018 results  
    Sky News reports on Elixinol Global’s strong financial results  
    Elixinol Global doubles in size since ASX debut reports Small Caps